Brilliant Bio Pharma Private Limited

General Information
Company Name
Brilliant Bio Pharma Private Limited
Founded Year
1988
Location (Offices)
Founders / Decision Makers
Number of Employees
161
Industries
Health Care, Pharmaceutical
Funding Stage
-
Social Media

Brilliant Bio Pharma Private Limited - Company Profile

Brilliant Bio Pharma Private Limited (BBPL) is a member company of TGV conglomerate engaged in the manufacture of Veterinary Biologicals and Medicines. The group, with diverse activities in Industrial Chemicals, Aquaculture, Salt, Power, Health Care, Hospitality Industry, Personal Care Products, and Veterinary Biologicals and Medicines, has received prestigious awards such as the “National Award for Safety”, “National Award for Environment”, and the “National Award for R&D”. Founded in 1988 in Hyderabad, the company boasts a state-of-the-art manufacturing facility accredited with WHO GMP and ISO 9001-2008 certifications. Mrs. Mourya Boda took over as Chairperson & Managing Director in 2005. The vaccines, manufactured using modern technology, are certified for safety, sterility, and potency as per various Pharmacopeial standards. Additionally, their product profile includes a wide range of Animal Health Products. BBPPL has a strong presence in domestic and international markets, with products registered and exported to various countries in South East Asia, Gulf, Middle East, Far East, CIS Countries, Africa, and Latin America. For more information, visit www.tgvgroup.com. This company presents an opportunity for investment in the Health Care and Pharmaceutical industries.

Funding Rounds & Investors of Brilliant Bio Pharma Private Limited (0)

View All

There is no investment information

Latest News of Brilliant Bio Pharma Private Limited

View All

No recent news or press coverage available for Brilliant Bio Pharma Private Limited.

Similar Companies to Brilliant Bio Pharma Private Limited

View All

No funding or investment information available for Brilliant Bio Pharma Private Limited at this time.